Advanced TAVR Symposium Agenda

The course comprises six sessions, with discussion and audience Q&A following each main topic.

Course Directors
Gorav Ailawadi, MD, MBA, Ann Arbor, MI
Michael A. Borger, MD, PhD, Leipzig, Germany
Tsuyoshi Kaneko, MD, Boston, MA
Molly A. Szerlip, MD, Plano, TX


	Introduction Gorav Ailawadi, MD, MBA, Ann Arbor, MI Michael A. Borger, MD, PhD, Leipzig, Germany

TAVR in Low-Risk Patients
Moderators: Michael A. Borger, MD, PhD, Leipzig, Germany, Joanna Chikwe, MD, FRCS, Los Angeles, CA, and Mark J. Russo, MD, MS, New Brunswick, NJ
	What Is the Landscape of TAVR in 2021? Vinod H. Thourani, MD, Atlanta, GA
	New AHA/ACC Guidelines – Class I Indication for 65-Year-Old Patient with Aortic Stenosis Patrick T. O’Gara, MD, Boston, MA
	TAVR for 65-Year-Old Patient with Tricuspid Aortic Stenosis – Surgeon’s Perspective Vinayak N. Bapat, MD, London, United Kingdom
	TAVR for 65-Year-Old Patient with Tricuspid Aortic Stenosis – Interventional Cardiologist’s Perspective Susheel K. Kodali, MD, New York, NY
	Lifetime Management of Aortic Stenosis Tsuyoshi Kaneko, MD, Boston, MA
	Live Discussion and Q&A

Valve-in-Valve TAVR
Moderators: Anita R. Krueger, MD, Forth Worth, TX, and S. Christopher Malaisrie, MD, Chicago, IL
	Data on Valve-in-Valve TAVR Guilherme F. Attizzani, MD, Cleveland, OH
	Step-by-Step BASILICA Technique Kendra J. Grubb, MD, MHA, Atlanta, GA
	TAV-in-TAV – What Do We Know? John G. Webb, MD, Vancouver, BC, Canada
	Balloon Valve Fracturing for All Keith B. Allen, MD, Kansas City, MO
	Live Discussion and Q&A

Break

Controversies in Bicuspid TAVR
Moderators: Gorav Ailawadi, MD, MBA, Ann Arbor, MI, and Karen M. Kim, MD, Ann Arbor, MI
	Guideline Recommendation for Bicuspid Aortic Valve Stenosis Nimesh D. Desai, MD, PhD, Philadelphia, PA
	Is There a Need for a Different Classification? Pinak B. Shah, MD, Boston, MA
	TAVR for All Bicuspids Rajendra R. Makkar, MD, Los Angeles, CA
	Surgery for All Bicuspids Joseph E. Bavaria, MD, FRSC(Ed), Philadelphia, PA
	Do We Need a Randomized Control Study? Michael J. Mack, MD, Plano, TX
	Live Discussion and Q&A

Alternative Access for Surgeons: Which One Would You Choose?
Moderators: Walid Ben Ali, MD, PhD, Montreal, Canada, Ourania A. Preventza, MD, MBA, Houston, TX, and Basel Ramlawi, MD, Wynnewood, PA
	Transcarotid TAVR Thomas Modine, MD, PhD, MBA, Lille, France
	Percutaneous Axillary TAVR James M. McCabe, MD, Seattle, WA
	Transinnominate TAVR Isaac George, MD, New York, NY
	Transcaval TAVR Adam Greenbaum, MD, Atlanta, GA
	Live Discussion and Q&A

Lunch/Industry Symposium

TAVR Explant – New Specialty for Cardiac Surgery
Moderators: Wilson Y. Szeto, MD, Philadelphia, PA, Moritz C. Wyler von Ballmoos, MD, PhD, MPH, Houston, TX, and Jessica Forcillo, MD, MSc, MPH, Montreal, Canada
	What Are the Data on TAVR Explant? Paolo Denti, MD, Milan, Italy
	Would TAVR Explant Change Your Point of View on TAVR in Low-Risk Patients? Molly A. Szerlip, MD, Plano, TX
	Techniques of TAVR Explant: BAV Tom C. Nguyen, MD, San Francisco, CA
	Techniques of TAVR Explant: SEV Shinichi Fukuhara, MD, Ann Arbor, MI
	Techniques of Sutureless Valve Explant Eric E. Roselli, MD, Cleveland, OH
	Live Discussion and Q&A

Optimizing TAVR
Moderators: Marc P. Pelletier, MD, MSc, Cleveland, OH, and Thomas Walther, MD, PhD, Frankfurt, Germany
	Commissural Alignment – Replicating Surgical Aortic Valve Replacement-Like Results Gilbert H.L. Tang, MD, MSc, MBA, New York, NY
	Cerebral Embolic Protection Device – Is It Needed? Amar Krishnaswamy, MD, Cleveland, OH
	TAVR for Aortic Insufficiency – Is It Coming? David A. Wood, MD, Vancouver, BC, Canada
	Future of TAVR – Upcoming Reiterations and New Devices Michael J. Reardon, MD, Houston, TX
	Live Discussion and Q&A

Closing Remarks
Tsuyoshi Kaneko, MD, Boston, MA
Molly A. Szerlip, MD, Plano, TX

Schedule and speakers subject to change.